FAQs for Business Development and Partnering
What types of corporate partnerships or business opportunities are available at Boston Children’s Hospital?
Our investigators are bringing genomics, proteomics, gene therapy and editing, vaccines, informatics, drug delivery technologies and other cutting-edge disciplines to bear on age-old diseases, including immune disorders, hereditary illness, congenital disorders, and cancers. TIDO provides access to Boston Children’s researchers and their discoveries though exclusive and non-exclusive licenses, collaboration agreements, sponsored research and startup creation. We also explore non-traditional ways of structuring partnerships that allow both the investigator and the partnering company to get the most benefit.
Who do I contact about business opportunities?
Call TIDO at (617) 919-3019 or email Amy Miracco, PhD, Business Development Specialist.
What technologies does Boston Children’s Hospital have for licensing or co-development?
Boston Children’s has therapeutic, diagnostic, device, software, drug delivery and research tool technologies. A searchable list of technologies available for licensing can be found here.
How mature are Boston Children’s Hospital technologies?
Boston Children’s has funded additional development of approximately 64 technologies since the inception of the Technology Development Fund in 2009. Please see information about the Technology Development Fund and its funded projects.
I am an entrepreneur looking for technologies to develop. How do I find these opportunities at Boston Children’s?
Boston Children’s offers a wide range of platform technologies and IP portfolios to form the basis of a startup company. For information about specific opportunities, please call Amy Miracco at (617) 919-2721.
What are typical license terms?
Our license agreement terms follow customary and reasonable industry standards and include the following provisions:
- up-front, milestone and/or ongoing royalty payments for Boston Children’s to share in the financial return from our investment
- coverage (by Boston Children’s) of costs related to obtaining and maintaining patents
- licensee diligence requirements to ensure that the intellectual property is optimally utilized for the benefit of patients
- reservation of the unrestricted right for investigators at Boston Children’s to continue to use the inventions for research
- indemnification provisions to protect Boston Children’s from product liability and other claims arising from the commercialization of the technology
- other customary terms for a license.
We are looking for expertise in a specific disease area. How can we make contact with a Boston Children’s Hospital researcher?
Call or email Amy Miracco, PhD, Business Development Specialist and she can direct you to researchers in specific disease areas. You can also search within a specific area on Boston Children’s researcher search page.
Does Boston Children’s have technologies for adult indications?
Yes. Although we are a pediatric hospital, our research labs seek to identify factors that contribute to both childhood and adult diseases — and to develop effective treatments for them.
May I contact investigators directly?
We encourage companies to contact TIDO to talk with an investigator. We can direct you to the appropriate researcher, put the necessary agreements in place and set up a meeting. Call us at (617) 919-3019 or email tido@childrens.harvard.edu.